Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse

Eur J Pharmacol. 1995 Jul 4;280(2):R1-3. doi: 10.1016/0014-2999(95)00322-c.


A specific protein kinase C inhibitor, calphostin C, which injected alone had no effect on the antinociception induced by intrathecal (i.t.) administration of a selective mu-opioid receptor agonist, [D-Ala2,NMePhe4,Gly(ol)5]enkephalin (DAMGO), dose-dependently attenuated the development of acute tolerance to the i.t. DAMGO-induced antinociception in male ICR mice. On the other hand, a selective protein kinase A inhibitor, KT5720, did not have any effect on the development of acute tolerance to DAMGO antinociception. These findings suggest that protein kinase C, but not protein kinase A, plays an important role in the development of acute tolerance to the mu-opioid receptor agonist-induced antinociception.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analgesics / pharmacology*
  • Animals
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors*
  • Dose-Response Relationship, Drug
  • Drug Tolerance
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Enkephalins / pharmacology
  • Injections, Spinal
  • Male
  • Mice
  • Mice, Inbred ICR
  • Protein Kinase C / antagonists & inhibitors*
  • Receptors, Opioid, mu / agonists*


  • Analgesics
  • Enkephalins
  • Receptors, Opioid, mu
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C